Innovation und Networking: expopharm 2025 unites the industry
From September 16–18, 2025, expopharm in Düsseldorf will bring together new exhibitors, forward-looking formats, and a strong network for the pharmacy and healthcare sector.
Healthcare marketing 2025: efficient and data-driven
In 2025, marketers will increasingly rely on smart targeting and omnichannel concepts to achieve maximum impact with shrinking budgets.
BioNTech Acquires CureVac: Focus on mRNA for Cancer
BioNTech announces the full acquisition of CureVac to significantly expand its mRNA research and cancer therapy platform. The transaction strengthens Germany’s role in the global biotech landscape.
Merck Acquires SpringWorks for $3.4 Billion
Merck drives growth in its Healthcare business with the $3.4 billion acquisition of SpringWorks Therapeutics, expanding into rare tumor therapies.
Free Blood Test for Cats: Take Precaution Now!
Many cats suffer from undetected diseases. Boehringer Ingelheim now offers free blood tests for cats nationwide – redeemable with a voucher until August 15, 2025.
Risks of Automatic Substitution of Biopharmaceuticals
Automatic substitution of biopharmaceuticals poses major risks to patient care and Germany’s pharmaceutical sector, leading industry associations warn.
Pneumococcal Infections on the Rise – Vaccination Rates Still Low
While the flu wave has peaked, pneumococcal infections are on the rise. Older people are especially at risk – vaccination offers effective protection.
Vetter Recognized Again as Best Managed Company
Vetter has once again been recognized as a “Best Managed Company” in its anniversary year. The award honors the company's strategic focus and sustainable management approach.
Pharmacy and Science: A Glimpse into the Future
INTERPHARM 2025 in Stuttgart delivers cutting-edge insights into autoimmune diseases, skin health, eye care, and the future of healthcare. Discover the highlights now!
Health Insurers Warn: Premium Surcharges to Rise Again
Germany’s public health insurers warn of rising premium surcharges. Hospital stays, medication costs, and more severe illnesses are driving up expenses.
EU reviews producer responsibility in wastewater directive
The EU Commission is reviewing the costs and impacts of extended producer responsibility in the Urban Wastewater Directive. Pharma Germany welcomes the move.
Reimbursable Medications for Smoking Cessation Approved
Patients with severe tobacco addiction can now receive reimbursable medications like nicotine or varenicline as part of certified cessation programs.
ITM Secures Up to $262.5M in Financing from Blue Owl
ITM secures up to $262.5M from Blue Owl to support the commercialization of ITM-11 and expand its radiopharmaceutical pipeline.
Health Policy in the Spotlight: German Medical Assembly in Leipzig
The 129th German Medical Assembly is bringing healthcare policy to Leipzig – with Health Minister Nina Warken and topics like AI, fee regulation, and abortion on the agenda.
Hope for Pulmonary Fibrosis Patients: New Drug Candidate Emerges
With Nerandomilast, Boehringer Ingelheim presents a groundbreaking drug candidate that could transform the treatment of pulmonary fibrosis. Phase III studies show first positive results in over a decade.
Court Overturns Ruling: FOCUS Doctor Seals Remain Valid
The Munich court has overturned the ban on FOCUS doctor seals—recommended physicians may continue to display their distinction publicly.
OTC Market 2025 Continues Growth
The OTC market saw solid growth again in 2024, affirming its role as a key pillar of Germany’s healthcare system. Every second medicine sold in pharmacies is now non-prescription.
Biotech: Startup Boom, Revenue Slump
Following a record year for startup funding in 2024, Germany’s biotech industry is now facing declining revenues and a sudden drop in investor interest in early 2025.
Public Concern Over Environmental Health Risks Declining, Says AOK Study
According to the latest WIdOmonitor by AOK, public awareness of environmental risks and their impact on health is steadily declining. Air pollution in particular is viewed with less concern.
Paul-Ehrlich-Institut Launches Digital Awareness Campaign Against Misinformation
The German Paul-Ehrlich-Institut is countering vaccine misinformation with a new digital campaign: #ImpfstoffFakten (VaccinationFacts) vs. Myths.